High serum creatinine is associated with reduction of vision impaired in patients with NMOSD

J Neuroimmunol. 2017 Sep 15:310:32-37. doi: 10.1016/j.jneuroim.2017.06.003. Epub 2017 Jun 13.

Abstract

Serum creatinine (SCR) has been found to be neuroprotective in neurodegenerative disease. However, whether SCR is a protective factor for vision impaired in neuromyelitis optica spectrum disorder (NMOSD) is unclear. This study to determine the relationship between SCR level and vision impaired in NMOSD patients through multivariate-adjusted linear regression analyses. Our result showed that high level of SCR was associated with a low occurrence of vision impaired, and the association was independent after adjustment for confounding risk factors and hierarchical analysis. Therefore, these results demonstrated that higher SCR level is a protective factor of vision impaired in male NMOSD patients.

Keywords: Immune disease; Multivariate analysis; NMOSD; Serum creatinine; Vision impaired.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aquaporin 4 / immunology
  • Creatine / blood*
  • Cross-Sectional Studies
  • Disability Evaluation
  • Female
  • Humans
  • Immunoglobulin G / blood
  • Linear Models
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neuromyelitis Optica / complications*
  • Neuromyelitis Optica / diagnostic imaging
  • Retrospective Studies
  • Severity of Illness Index
  • Vision Disorders / blood*
  • Vision Disorders / diagnostic imaging
  • Vision Disorders / etiology*
  • Young Adult

Substances

  • AQP4 protein, human
  • Aquaporin 4
  • Immunoglobulin G
  • Creatine